Publications by authors named "Rajesh Solanki"

Claim this Profile
C
Clinico-demographic profile of pre-extensively drug-resistant pulmonary tuberculosis patients in India.
Bella Devaleenal Daniel, M Muthuvijayalakshmi, Vikas Oswal, Chetan Kumar Jain, Neeta Singla, Rajesh Solanki

Indian J Tuberc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study on Evaluation of Patient Satisfaction with National Tuberculosis Elimination Programme Services in Ahmedabad, India.
Rujul Shukla, Sahil Solanki, Viral Dave, Bhavesh Modi, Rajesh Solanki

Indian J Community Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
Ruth L Goodall, Andrew J Nunn, Sarah K Meredith, Adamu Bayissa, Anuj K Bhatnagar, Rajesh Solanki

Lancet Respir Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of anxiety and depression among tuberculosis patients of Ahmedabad, India.
Sahil R Solanki, Viral R Dave, Rujul P Shukla, Vasu G Rathod, Rajesh N Solanki

Indian J Tuberc· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Bedaquiline and Delamanid Pharmacokinetics on Sputum Culture Conversion and Adverse Events in Drug-Resistant Tuberculosis.
Anuj K Bhatnagar, Agibothu Kupparam Hemanthkumar, Mariappan Muthu Vijayalakshmi, Vikram Vohra, Chandrasekaran Padmapriyadarsini, Rajesh Solanki

Ther Drug Monit· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Intake of Linezolid Elevates Drug Exposure and Reduces Drug Clearance and Elimination in Adults With Drug-Resistant Pulmonary Tuberculosis.
Shanmugam Murugaiha Jeyakumar, Namrata K Bhui, Neeta Singla, Sudha Vilvamani, Muthu Vijayalakshmi Mariappan, Rajesh Solanki

Ther Drug Monit· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis.
Chandrasekaran Padmapriyadarsini, Rajesh Solanki, S M Jeyakumar, Anuj Bhatnagar, M Muthuvijaylaksmi

Antibiotics (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial.
Laura Rosu, Jason J Madan, Ewan M Tomeny, Malaisamy Muniyandi, Jasper Nidoi, Rajesh Solanki

Lancet Glob Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Ruth L Goodall, Sarah K Meredith, Andrew J Nunn, Adamu Bayissa, Anuj K Bhatnagar, Rajesh Solanki

Lancet· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.
Chandrasekaran Padmapriyadarsini, Vikram Vohra, Anuj Bhatnagar, Rajesh Solanki, Rathinam Sridhar

Clin Infect Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-conference workshop on drug resistant TB - NATCON 2020.
Rupak Singla, Sarabjit S Chadha, Anuj Bhatnagar, Rajesh Solanki, Ashwani Khanna

Indian J Tuberc· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early treatment outcome of bedaquiline plus optimised background regimen in drug resistant tuberculosis patients.
Sandip V Barvaliya, Mira K Desai, Jigar R Panchal, Rajesh N Solanki

Indian J Tuberc· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania.
Khadija Said, Jerry Hella, Mwajabu Ruzegea, Rajesh Solanki, Magreth Chiryamkubi

Pediatr Infect Dis J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkrein Deformity of the Great toe Managed by Midfoot Flexor Hallucis Longus Z-Plasty: A Case Report.
Mohnish V Gadhavi, Drumil D Majmundar, Rajesh A Solanki

J Orthop Case Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India.
Krunal Prajapati, Vishal Mishra, Mira Desai, Rajesh Solanki, Purvi Naik

Int J Mycobacteriol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
Paresh Dave, Bhavin Vadera, Ajay M V Kumar, Palanivel Chinnakali, Bhavesh Modi, Rajesh Solanki

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
Neeraj Raizada, K S Sachdeva, D S Chauhan, Bharti Malhotra, Kishore Reddy, Rajesh Solanki

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis.
Kalpesh Jain, Mira Desai, Rajesh Solanki, Ram Kumar Dikshit

J Pharmacol Pharmacother· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead.
Surendra K Sharma, Alladi Mohan, L S Chauhan, J P Narain, P Kumar, Rajesh Solanki

Indian J Med Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-resistant tuberculosis: new challenges.
Rajesh N Solanki

Indian J Chest Dis Allied Sci· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the RNTCPIRL-EQA-OSE visits on quality of sputum smear microscopy services of Gujarat, India.
Nilesh D Patel, Kiran Rade, Paresh V Dave, Kirit Pujara, Rajesh N Solanki

Indian J Tuberc· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proficiency panel testing--a reliable tool in external quality assessment of sputum smear microscopy services in Gujarat, India.
Paresh V Dave, Nilesh D Patel, K Rade, Rajesh N Solanki, P G Patel

Indian J Tuberc· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angioimmunoblastic lymphadenopathy with dysproteinemia: thoracic involvement.
Manoj K Singh, Rajesh N Solanki, Nikhil J Shah, Dhiren Tanna, Dilip R Patel

Indian J Chest Dis Allied Sci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis